Initial Experience with Single Lead Intracardial Cardioversion for Refractory Atrial Fibrillation

Overview

Journal Neth Heart J

Specialty Cardiology & Vascular Diseases

Date 2015 Feb 20

PMID 25696733

Authors

H A van de Klippe

C P Allaart

J H Ruiter

Affiliations

Soon will be listed here.

Abstract

Background: Chronic atrial fibrillation (AF) is a common arrhythmia, associated with a substantial morbidity (thromboemboli, worsening left ventricular function). Established therapy for pharmacological refractory AF is high-energy trans-thoracic electric cardioversion (TTCV), but this strategy is ineffective for 10-30% of the patients. The purpose of the present study is to establish the safety and efficacy of low-energy intracardiac cardioversion (ICCV) with a relatively new balloon-guided single-catheter system with dual chamber pacing possibility for this group of patients.

Methods: Patients in whom an attempt to restore sinus rhythm (SR) by TTCV under antiarrhythmic therapy failed were eligible for the study. For the ICCV-attempt, a single flow-guided atrial cardioversion catheter was used. Low-energy biphasic shocks of increasing energy (6-15 J) were delivered, if necessary in combination with intravenous amiodarone, until SR was restored. In case of early recurrence of AF, another attempt was made with immediate post-shock overdrive pacing (AOO) in order to suppress premature atrial activity.

Results: Initially, 14 of the 16 treated patients (90%) were converted to SR successfully. In eight patients additional amiodarone i.v. was administered and in six patients atrial overpacing was used after ICCV. In seven and five patients, respectively, these strategies were successful. Long-term follow-up (1-3 months) showed that in nine patients (56%) SR was preserved; eight of them on oral amiodarone. No adverse events were seen during the procedure and follow-up, especially no bleedings, despite puncturing under adequate anticoagulation therapy.

Conclusion: ICCV using a single atrial cardioversion catheter is a safe and effective method to restore SR in patients in whom TTCV failed previously. Long-term follow-up of this procedure is comparable to that of other studies. Results are influenced by antiarrhythmic drug therapy, compliance and patient selection.

References

Schmitt C, Alt E, Plewan A, Ammer R, Leibig M, Karch M . Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol. 1996; 28(4):994-9. DOI: 10.1016/s0735-1097(96)00274-4. View

Saliba W, Juratli N, Chung M, Niebauer M, Erdogan O, Trohman R . Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation. J Am Coll Cardiol. 1999; 34(7):2031-4. DOI: 10.1016/s0735-1097(99)00463-5. View

Santini M, Pandozi C, Toscano S, Castro A, Altamura G, Jesi A . Low energy intracardiac cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol. 1999; 21(12):2641-50. DOI: 10.1111/j.1540-8159.1998.tb00041.x. View

Wijffels M, Kirchhof C, Dorland R, Allessie M . Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995; 92(7):1954-68. DOI: 10.1161/01.cir.92.7.1954. View

Capucci A, Villani G, Aschieri D . Risk of complications of atrial fibrillation. Pacing Clin Electrophysiol. 1997; 20(10 Pt 2):2684-91. DOI: 10.1111/j.1540-8159.1997.tb06117.x. View

Paravolidakis K, Kolettis T, Theodorakis G, Paraskevaidis I, Apostolou T, Kremastinos D . Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation. J Interv Card Electrophysiol. 1998; 2(3):249-53. DOI: 10.1023/a:1009732903788. View

Tse H, Lau C, Ayers G . Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart. 1999; 82(3):319-24. PMC: 1729161. DOI: 10.1136/hrt.82.3.319. View

Yu W, Lin Y, Tai C, Tsai C, Hsieh M, Chen C . Early recurrence of atrial fibrillation after external cardioversion. Pacing Clin Electrophysiol. 1999; 22(11):1614-9. DOI: 10.1111/j.1540-8159.1999.tb00380.x. View

Ideker R, Wolf P, Alferness C, Krassowska W, Smith W . Current concepts for selecting the location, size and shape of defibrillation electrodes. Pacing Clin Electrophysiol. 1991; 14(2 Pt 1):227-40. DOI: 10.1111/j.1540-8159.1991.tb05093.x. View

10.

Neri R, Palermo P, Cesario A, Baragli D, Amici E, Gambelli G . Internal cardioversion of chronic atrial fibrillation in patients. Pacing Clin Electrophysiol. 1997; 20(9 Pt 1):2237-42. DOI: 10.1111/j.1540-8159.1997.tb04242.x. View

11.

Boriani G, Biffi M, Pergolini F, Zannoli R, Branzi A, Magnani B . Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year. Pacing Clin Electrophysiol. 1999; 22(1 Pt 2):243-6. DOI: 10.1111/j.1540-8159.1999.tb00341.x. View

12.

Plewan A, Valina C, Herrmann R, Alt E . Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing. Pacing Clin Electrophysiol. 1999; 22(1 Pt 2):228-32. DOI: 10.1111/j.1540-8159.1999.tb00338.x. View

13.

Suttorp M, Kingma J, Jessurun E, Lie-A-Huen L, van Hemel N, Lie K . The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol. 1990; 16(7):1722-7. DOI: 10.1016/0735-1097(90)90326-k. View

14.

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg M, Green M . Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000; 342(13):913-20. DOI: 10.1056/NEJM200003303421302. View

15.

Flaker G, Blackshear J, McBride R, Kronmal R, Halperin J, Hart R . Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992; 20(3):527-32. DOI: 10.1016/0735-1097(92)90003-6. View

16.

Singh S, Saini R, DiMarco J, Kluger J, Gold R, Chen Y . Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. Am J Cardiol. 1991; 68(11):1227-30. DOI: 10.1016/0002-9149(91)90200-5. View

17.

Ammer R, Alt E, Ayers G, Lehmann G, Schmitt C, Pasquantonio J . Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. Pacing Clin Electrophysiol. 1997; 20(1 Pt 2):230-6. DOI: 10.1111/j.1540-8159.1997.tb04849.x. View

18.

Oral H, Souza J, Michaud G, Knight B, Goyal R, Strickberger S . Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 1999; 340(24):1849-54. DOI: 10.1056/NEJM199906173402401. View

19.

Antman E, Beamer A, Cantillon C, McGowan N, Friedman P . Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 1990; 15(3):698-707. DOI: 10.1016/0735-1097(90)90649-a. View

20.

Mehdirad A, Clem K, Love C, Nelson S, Schaal S . Improved clinical efficacy of external cardioversion by fluoroscopic electrode positioning and comparison to internal cardioversion in patients with atrial fibrillation. Pacing Clin Electrophysiol. 1999; 22(1 Pt 2):233-7. DOI: 10.1111/j.1540-8159.1999.tb00339.x. View